PLIANT THERAPEUTICS INC (PLRX) Stock Balance Sheet
NASDAQ:PLRX - Nasdaq - US7291391057 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 91.94M | 71.19M | 63.23M | 33.70M | 51.70M | |||
| Marketable Securities | 213.71M | 284.54M | 431.01M | 297.50M | 148.90M | |||
| Receivables | 1.68M | 2.30M | 3.00M | 2.10M | 2.10M | |||
| Other Current Assets | 3.86M | 4.24M | 8.26M | 7.10M | 6.80M | |||
| Total Current Assets | 311.19M | 362.26M | 505.50M | 340.30M | 209.40M | |||
| Non-Current Assets | ||||||||
| PPE Net | 31.67M | 32.77M | 4.78M | 9.90M | 10.90M | |||
| Other Non-Current Assets | 1.91M | 1.92M | 1.87M | 400.00K | 800.00K | |||
| Total Non-Current Assets | 33.58M | 34.69M | 6.65M | 10.30M | 11.80M | |||
| TOTAL ASSETS | 344.77M | 396.95M | 512.15M | 350.60M | 221.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 1.87M | |||
| Accrued Expenses | 22.58M | 27.26M | 23.99M | 22.30M | 13.90M | |||
| Accounts Payable | 5.62M | 5.96M | 4.53M | 1.60M | 3.00M | |||
| Total Current Liabilities | 28.20M | 33.22M | 28.52M | 23.90M | 16.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 30.28M | 30.21M | 10.05M | 9.90M | 0.00 | |||
| Other Non-Current Liabilities | 29.12M | 29.44M | 0.00 | 3.40M | 5.30M | |||
| Total Non-Current Liabilities | 59.40M | 59.65M | 10.05M | 13.40M | 5.40M | |||
| TOTAL LIABILITIES | 87.61M | 92.87M | 38.58M | 37.30M | 22.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -766.22M | -710.05M | -499.75M | -338.40M | -215.10M | |||
| Additional Paid In Capital | 1.02B | 1.01B | 972.97M | 653.70M | 414.30M | |||
| Common Shares | 6.00K | 6.00K | 6.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 159.00K | 321.00K | 345.00K | -2.00M | -200.00K | |||
| Shares Outstanding | 61.39M | 60.86M | 59.92M | 48.90M | 36.10M | |||
| Tangible Book Value per Share | 4.19 | 5.00 | 7.90 | 6.41 | 5.52 | |||
| Total Shareholders' Equity | 257.16M | 304.08M | 473.58M | 313.30M | 199.10M | |||
| TOTAL LIABILITIES AND EQUITY | 344.77M | 396.95M | 512.15M | 350.60M | 221.20M | |||
| Statistics | ||||||||
| Debt/Equity | 0.12 | 0.10 | 0.02 | 0.03 | N/A | |||
| Current Ratio | 11.03 | 10.91 | 17.72 | 14.24 | 12.46 | |||
| Return On Assets (ROA) | -63.67% | -52.98% | -31.50% | -35.17% | -43.97% | |||
| Return On Equity (ROE) | -85.36% | -69.16% | -34.07% | -39.36% | -48.85% | |||
All data in USD , ROIC based on taxRate of 0.21